Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
---|
07/02/1996 | US5532234 Use of 1-[4-[4-aryl (or heteroaryl)-1-piperazinyl]-butyl)-1H-azole derivatives for the preparation of medicaments intended for the treatment of disorders of gastric secretion |
07/02/1996 | US5532233 Platelet activating factor antagonist |
07/02/1996 | US5532152 Platelet-activating factor acetylhydrolase |
07/02/1996 | US5531992 Antiinflammatory |
07/02/1996 | US5531989 Immunoglobulin and fiber-containing composition for human gastrointestinal health |
07/02/1996 | CA1338432C Esters of 3-demethylthiocolchicine and n-acyl analogs |
06/29/1996 | CA2166168A1 Esculetin derivatives, method for manufacture thereof, and pharmaceutical composition |
06/27/1996 | WO1996019228A1 Formulations and methods for reducing skin irritation |
06/27/1996 | WO1996019198A1 Aerosol drug formulations |
06/27/1996 | WO1996019183A1 Formulations and methods for reducing skin irritation |
06/27/1996 | WO1996019119A1 Silicone compositions |
06/27/1996 | CA2208268A1 Formulations and methods for reducing skin irritation |
06/26/1996 | EP0718299A1 Tricyclic oxime ethers process for their preparation and pharmaceutical compositions containing them |
06/26/1996 | EP0718294A1 2-Amino-1,3-thiazepines and their use as inhibitors of the nitrogene oxide synthase |
06/26/1996 | EP0717998A1 Use of substance P antagonist for the treatment of pruritis, eye or eyelid pain or disesthesies |
06/26/1996 | EP0717995A2 Cell degeneration suppressing and organ toxicity reducing agent |
06/26/1996 | EP0717739A1 Bicyclic aromatic compounds as therapeutic agents |
06/26/1996 | EP0717732A1 Polyamidic acid derivatives with antigastrin activity, a method for their preparation, and their pharmaceutical use |
06/26/1996 | EP0717635A1 Methods for regulating gastrointestinal motility |
06/26/1996 | EP0717625A1 A method of treating liver disease and like indications with vasodilating agents |
06/26/1996 | EP0717623A1 Epibatidine and derivatives thereof as cholinergic receptor agonists and antagonists |
06/26/1996 | EP0579770B1 Macrocyclic lactam prokinetic agents |
06/26/1996 | CN1125438A New active compounds |
06/26/1996 | CN1125398A Immunomodulatory, anti-inflammatory, and anti-proliferative compounds: 5,6-dideoxy, 5-amino derivatives of idose and 6-deoxy, 6-amino derivatives of glucose |
06/25/1996 | US5530128 Enzyme inhibitor as antitumor agent |
06/25/1996 | US5530009 Treating asthma |
06/25/1996 | CA2003692C Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract and additional applications for surfactant replacement therapy and other conditions requiring rapid phospholipid _absorption to surfaces |
06/25/1996 | CA1338420C Substituted .beta.-diketones |
06/20/1996 | WO1996018419A1 Recombinant vectors for permanent reconstitution of liver and treatment of hepatitis c |
06/20/1996 | WO1996018418A1 Improved adenoviral vectors and producer cells |
06/20/1996 | WO1996018411A1 Localized delivery of factors enhancing survival of transplanted cells |
06/20/1996 | WO1996018393A1 Novel compounds |
06/20/1996 | WO1996004254A3 Benzodiazepine derivatives |
06/20/1996 | CA2206683A1 Improved adenoviral vectors and producer cells |
06/19/1996 | EP0716650A1 Indole and indoline derivatives as 5ht1d receptor antagonists |
06/19/1996 | EP0716603A1 Methods and compositions for inhibiting uridine secretion |
06/19/1996 | EP0716598A1 Pharmaceutical preparations for the targeted treatment of morbus crohn and colitis ulcerosa |
06/19/1996 | EP0578732B1 Chewable antacid compositions |
06/19/1996 | EP0571556B1 Non-antibacterial tetracycline compositions possessing antiplaque properties |
06/19/1996 | EP0489089B1 Therapeutic peptides |
06/19/1996 | CN1124961A Substituted pyrrolidin-3-Yl-alkyl-piperidines useful as tachykinin antagonists |
06/19/1996 | CN1124927A Analogs of peptide YY and uses thereof |
06/19/1996 | CN1124644A Medicine for tooth transplantation and producing process thereof |
06/18/1996 | US5527919 Process for the preparation of 1-[(1,1'-biphenyl]-4-YL]-methyl-1H-imidazole-5-carboxylic acids |
06/18/1996 | US5527817 N,n-dimethyl-2-(5-(1,2,4-triazol-1-ylmethyl)-1h-indol-3-yl) ethylamine; selective agonist of 5-ht1-like receptors; useful in treatment of migraines |
06/18/1996 | US5527776 Treatment of immunologic and hematologic disorders with IGFBP alone or complexed with IGF |
06/18/1996 | US5527548 Promotes digestibility of food product having acid character |
06/18/1996 | CA2091818C Method and apparatus for purifying islets of langerhans |
06/17/1996 | CA2165386A1 2-amino-1,3-thiazepines and their use as inhibitors of nitric oxide synthase |
06/13/1996 | WO1996017936A2 Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease |
06/13/1996 | WO1996017863A1 Induction of cytotoxic t-lymphocyte responses |
06/13/1996 | WO1996017838A1 Malonic acid based matrix metalloproteinase inhibitors |
06/13/1996 | WO1996017830A1 Compounds for inhibition of gastric acid secretion |
06/13/1996 | WO1996017613A1 Hepatic-directed compounds and reagents for preparation thereof |
06/13/1996 | WO1996017596A1 Liposomal interferon hybrid compositions |
06/13/1996 | WO1996009038A3 Alteration of activity and/or levels of haem-oxygenase to control inflammation |
06/13/1996 | WO1996006620A3 Lipid analogs for treating viral infections |
06/13/1996 | CA2207292A1 Liposomal interferon hybrid compositions |
06/13/1996 | CA2207096A1 Hepatic-directed compounds and reagents for preparation thereof |
06/13/1996 | CA2206665A1 Malonic acid based matrix metalloproteinase inhibitors |
06/13/1996 | CA2206664A1 Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease |
06/13/1996 | CA2205896A1 Compounds for inhibition of gastric acid secretion |
06/13/1996 | CA2204738A1 Induction of cytotoxic t-lymphocyte responses |
06/12/1996 | EP0715855A2 NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis |
06/12/1996 | EP0715624A1 Process for the preparation of benzodiazepine compounds useful as antagonists of cck or of gastrine |
06/12/1996 | EP0715519A1 Immunomodulatory, anti-inflammatory, and anti-proliferative compounds: 5,6-dideoxy, 5-amino derivatives of idose and 6-deoxy, 6-amino derivatives of glucose |
06/12/1996 | CN1124489A Tetracyclic compounds as dopamine agonists |
06/12/1996 | CN1124486A Heterocycle-containing amidine derivatives, their preparation and use |
06/12/1996 | CN1124485A Novel 1-phenylalkanone 5-HT4 receptor ligands |
06/12/1996 | CN1124454A Rectal compositions |
06/12/1996 | CN1124451A Liquid antacid compositions |
06/12/1996 | CN1032000C Process for preparing pyrazolidinone CCK and gastrin antagonists |
06/12/1996 | CN1031999C Process for preparing 6-substituted-tetrahydrobenz |CD¨ indoles |
06/12/1996 | CN1031998C |Alpha-(tert-butyl aminomethyl)-3,4-dichloro benzyl¨ thioacetamide, process for preparing them and application |
06/12/1996 | CN1031992C Quinone derivatives and pharmaceutical use |
06/11/1996 | US5525629 Inhibition of cytokine production |
06/11/1996 | US5525624 A 3-benzoyl,4-oxyphenylbenzothiophene compound |
06/11/1996 | CA2030397C 1-aryl-1-hydroxy-1-substituted-3-(4-substituted-1- piperazinyl)-2-propanones and their use in treatment of neurogenic bladder disorders |
06/11/1996 | CA2005950C Non-a, non-b hepatitis virus genome rna, cdna and virus antigen protein |
06/06/1996 | WO1996017077A1 Enantioselective preparation of pharmaceutically active sulfoxides by bioreduction |
06/06/1996 | WO1996017076A1 Enantioselective preparation of pharmaceutically active sulfoxides by biooxidation |
06/06/1996 | WO1996016970A1 Substituted 2-(phosphinyloxymethyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof |
06/06/1996 | WO1996016955A1 Processes and intermediates for preparing cis(+)3-[4,-6-dihydroxychroman-3-ylmethyl]-4-methoxyaniline |
06/06/1996 | WO1996016952A1 2-substituted 1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof |
06/06/1996 | WO1996016939A1 Perhydroisoindole derivatives as antagonists of substance p |
06/06/1996 | WO1996016934A1 Substituted biphenyl compounds for the treatment of inflammation |
06/06/1996 | WO1996016931A1 Metalloproteinase inhibitors |
06/06/1996 | WO1996016929A1 Novel multiple-substituent dtpa derivatives and metal complexes thereof, pharmaceutical compositions containing such complexes, their use in diagnosis and therapy, methods of preparing the complexing agents and complexes and methods of preparing the pharmaceutical compositions |
06/06/1996 | WO1996016928A1 Novel substituted dtpa derivatives, their metal complexes, pharmaceutical compositions containing these complexes and their use in diagnosis and therapy |
06/06/1996 | WO1996016677A2 Use of metal complexes as liver and gall bladder radiodiagnosis agents in computer tomography |
06/06/1996 | WO1996016654A1 2-(2,3,5,6-tetrafluoro-4-pyridyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof |
06/06/1996 | WO1996016542A1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) |
06/06/1996 | CA2206576A1 Dtpa derivatives substituted in a novel way, their metal complexes, pharmaceutical agents that contain these complexes and their use in diagnosis and therapy |
06/06/1996 | CA2206522A1 Novel, multiply substituted dtpa derivatives and their metal complexes, pharmaceutical agents that contain these complexes, their use in diagnosis and therapy, as well as process for the production of complexing agents and complexes and process for the production of pharmaceutical agents |
06/06/1996 | CA2206397A1 Use of metal complexes as liver and gall bladder x-ray diagnostic agentsin computer tomography |
06/06/1996 | CA2206257A1 Substituted biphenyl compounds for the treatment of inflammation |
06/06/1996 | CA2205972A1 Metalloproteinase inhibitors |
06/06/1996 | CA2205950A1 Substituted 2-(phosphinyloxymethyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof |
06/06/1996 | CA2205800A1 2-(2,3,5,6-tetrafluoro-4-pyridyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof |
06/06/1996 | CA2205799A1 2-substituted 1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof |